Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas

Journal of Clinical Pathology

Volumn 49, Issue 1, 1996, Pages 72-76

  Van Gorp, J ^a   Brink, A ^b   Oudejans, J J ^b   Van Den Brule, A J C ^b   Van Den Tweel, J G ^a   Jiwa, N M ^b   De Bruin, P C ^b   Meijer, C J L M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

EB virus encoded genes; T cell lymphoma

Indexed keywords

RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NOSE CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0030040767     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.1.72     Document Type: Article

References (34)

1. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128-30.
2. Ho FSC, Srivastava G, Loke SL, Fu KH, Leung BPY, Liang R, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and "T" cell type. Haematol Oncol 1990;8:271-81.
3. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17:392-9.
4. Kanavaros P, Lescs MC, Briere J, Divine M, Galateau F, Joab I, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81:2688-95.
5. Van Gorp J, Liu W, Jacobse K, Liu YH, Li FY, De Weger RA, et al. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 1994;173;81-7.
6. De Bruin PC, Jiwa M, Oudejans JJ, Van der Valk P, Van Heerde P, Sabourin JC, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994;83:1612-8.
7. Chan JKC, Yip TTC, Tsang WYW, Ng CS, Lau WH, Poon YF, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938-46.
8. Van Gorp J, De Bruin PC, Sie-Go DMDS, Van Heerde P, Ossenkoppele GJ, Rademakers LHPM, et al. Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathology 1995;27;139-48.
9. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 1987;6: 2743-51.
10. Brooks LA, Lear AL, Young LS, Rickinson AB. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 1993; 67:3182-90.
11. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993;177:339-49.
12. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus encoded latent gene prodnets in tumour cells of Hodgkin's disease. Lancet 1991; 337:320-2.
13. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992;66:2689-97.
14. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988;69:1051-65.
15. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, et al. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988;42:329-38.
16. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, Rickinson AB. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 1992;140:879-87.
17. Gratama JW, Zutter MM, Minarovits J, Oosterveer AP, Thomas ED, Klein G, et al. Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer 1991;47:188-92.
18. Young LS, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EB virus lymphoproliferative disease. N Engl J Med 1989; 321:1080-5.
19. Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, et al. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 1991;88:6343-7.
20. Smith PR, Griffin BE. Differential expression of Epstein-Barr virus gene EBNA1 from different promoters in nasopharyngeal carcinoma and B lymphoblastoid cells. J Virol 1992;66:706-14.
21. Cohen JI, Wang F, Mannick J, Kieff E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 1989;86:9558-62.
22. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993;90:9150-4.
23. Grogan E, Jenson H, Countryman J, Heston L, Gradoville J., Miller G. Tranfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. Proc Natl Acad Sci USA 1987;84:1332-6.
24. Carey M, Kolman J, Katz DA, Gradoville L, Barberis L, Miller G. Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA. J Virol 1902;66:4803-13.
25. Van Gorp J, Jacobse KC, Broekhuizen R, Alers J, Van den Tweel JG, De Weger RA. Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease. J Clin Pathol 1994;47:29-32.
26. Jiwa NM, Kanavaros P, Van der Valk P, Walboomers JMM, Horstman A, Vos W, et al. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells is independent of the presence of Epstein-Barr virus. J Clin Pathol 1993;46:211-7.
27. Oudejans JJ, Van den Brule AJC, Jiwa NM, De Bruin PC, Ossenkoppele GJ, Van der Valk P, et al. BHRF1 the Epstein-Barr virus (EBV) homologue of the bcl-2 (proto-) oncogene, is transcribed in EBV associated B-cell lymphomas and in reactive lymphocytes. Blood 1995;86:1893-902.
28. Lear AL, Rowe M, Kurilla G, Lee S, Henderson S, Kieff E, et al. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B-cells into the lytic cycle. J Virol 1992;66:7461-8.
29. Burkhardt AL, Bolen JB, Kieff E, Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol 1992;66: 5161-7.
30. Minarovits J, Hu LF, Imai S, Harabuchi Y, Kataura A, Minarovits-Kormuta S, et al. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T-cell lymphomas. J Gen Virol 1994;75:77-84.
31. Suzushima H, Asou N, Fujimotu T, Nishimura S, Okubo T, Yamasaki H, et al. Lack of EBNA2 and LMP1 in T-cell neoplasms possessing Epstein-Barr virus. Blood 1995; 85:480-6.
32. Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Rowe M, Young LS, Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 1991;78:1162-5.
33. Cochet C, Martel-Renoir D, Grunewald V, Bosq J, Cochet G, Schwaab G, et al. Expression of the Epstein-Barr virus immediate early gene, BZLF1 in nasopharyngeal carcinoma tumor cells. Virology 1993;197:358-65.
34. Gradoville L, Grogan E, Taylor N, Miller G. Differences in the extent of activation of Epstein-Barr virus replication gene expression among four non-producer cell lines stably transformed by OriP/BZLF1 plasmids. Virology 1900;178: 345-54.